News & Events about Biogen Inc.
Ticker Report
7 months ago
Biogen Inc. (NASDAQ:BIIB Get Rating) EVP Ginger Gregory sold 2,681 shares of the firms stock in a transaction dated Friday, April 28th. The shares were sold at an average price of $300.00, for a total transaction of $804,300.00. Following the transaction, the executive vice president ...
Biogen Inc. (NASDAQ:BIIB Get Rating) Equities researchers at Jefferies Financial Group reduced their Q3 2023 earnings per share estimates for Biogen in a note issued to investors on Tuesday, April 25th. Jefferies Financial Group analyst M. Yee now anticipates that the biotechnology company will earn...
Business Wire
7 months ago
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (PureTech or the Company) today announces its results for the year ended December 31, 2022, as well as its cash balance as of the first quarter ended March 31, 2023. The following information represents select highlights from the full UK annual report...
Fool.com Headlines
7 months ago
One is slightly cheaper than the other.When you think of biotech investing, you might focus on small companies that are years away from product revenue. They may eventually offer great rewards -- but at the moment, risk is high. If you're more of a cautious investor, that may not be your thing. That...